Riken Vitamin Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
12,706.00
11,909.00
7,857.00
20,313.00
-7.00
-6,979.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1,863.00
-1,453.00
-3,240.00
-1,155.00
3,927.00
9,758.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7,892.00
10,451.00
7,835.00
6,823.00
7,625.00
5,850.00
Cash Flow from Investing Activities
353.00
-554.00
-2,034.00
-3,661.00
-2,288.00
-4,282.00
Cash Flow from Financing Activities
-9,965.00
-7,084.00
-4,578.00
-7,565.00
-180.00
-3,051.00
Net Cash Inflow / Outflow
-1,307.00
3,485.00
1,592.00
-3,592.00
5,052.00
-1,552.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
413.00
672.00
369.00
811.00
-105.00
-69.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Riken Vitamin Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
12706
17641
-4,935.00
-27.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1863
-959
-904.00
-94.26%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7892
13204
-5,312.00
-40.23%
Cash Flow from Investing Activities
353
-3438
3,791.00
110.27%
Cash Flow from Financing Activities
-9965
-7372
-2,593.00
-35.17%
Net Cash Inflow / Outflow
-1307
2389
-3,696.00
-154.71%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
413
-5
418.00
8360.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -24.49% vs 33.39% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
7,892.00
10,451.00
-24.49%






